By Cambridge Polymer Group

At The MedTech Conference, “Medtech Moves Us” is more than a theme. It’s what happens when Medical device development often starts with a set of design requirements. A device must meet performance objectives, satisfy user needs, and function reliably in its intended environment. Those requirements provide an essential starting point, but they rarely capture every factor that will influence success as development moves forward.

We have seen a recurring pattern. An issue surfaces during validation, manufacturing, regulatory review, or following commercialization, and an apparent cause is identified. However, as the picture becomes clearer, it often turns out that the visible problem is only a symptom of a bigger issue.

Unfortunately for the designer, the decisions and assumptions behind that issue may have been in place for months or even years. Frequently, those decisions involve material selection that did not fully account for actual end-use requirements.

Engineering Requirements Are Only Part of the Problem

Material selection in device design usually begins with performance. If a device requires flexibility, durability, wear resistance, chemical compatibility, or a specific mechanical property, those needs naturally shape the selection process. The challenge is that the written performance requirements may not account for the specific conditions the device may encounter during production, transportation, storage, and clinical use.

A polymer that performs exactly as expected during early bench testing still must demonstrate safety and performance throughout the product lifecycle.

Material selection rarely remains a purely engineering decision. Performance must be considered alongside how the product will be made, tested, regulated, and used.

The Most Important Variable Is Not Always the Obvious One

Medical device development rarely involves choosing between a clearly good option and a clearly bad one. More often, teams are balancing competing priorities and trying to understand which tradeoffs matter most.

The history of orthopedic implants illustrates this well. Early designers correctly recognized that friction was important and selected materials accordingly. What became clear after early clinical studies was that wear resistance ultimately had a greater influence on long-term performance than friction alone. The difficulty was recognizing which material characteristic would matter most in real-world use and developing testing methods capable of reliably evaluating it.

Sterilization Deserves a Seat at the Table

A clear example is sterilization. Everyone understands sterilization is necessary. What is not always appreciated is how significantly sterilization can affect material behavior, particularly for polymers.

Depending on the material and sterilization method, changes in mechanical properties, wear behavior, dimensional stability, long-term performance, and safety can occur.

Sterilization is sometimes treated as a downstream decision because it does not fit neatly into a mechanical specification sheet. In practice, however, it can have a profound effect on material behavior, which is why it is usually better to consider it early, before the design becomes difficult to change.

The Supply Chain Matters More Than It Used To

Performance data alone does not determine the right material.

Supply chains have become a growing consideration for medical device developers. Material availability, second sourcing, supplier stability, and regulatory pressure on specific chemistries can all influence the long-term viability of a product.

PFAS materials provide a good example. Regardless of where individual regulations ultimately land, manufacturers are already having to evaluate how evolving requirements and supplier decisions could affect future material availability.

The technical answer and the practical answer are not always the same. A material can perform exceptionally well and still create risk if it becomes difficult to source, replace, or support at scale.

Regulatory Requirements Continue to Shape Design Decisions

Regulatory expectations evolve throughout development. Standards change, scientific understanding advances, and previously overlooked areas can become subjects of closer scrutiny.

Materials-related topics provide a good example. Expectations around chemical characterization, extractables and leachables, biological safety assessment, and aging studies have all evolved alongside improvements in analytical capabilities and scientific understanding.

Regulatory considerations influence development decisions from the outset. Teams that account for them early are generally better positioned to avoid surprises later.

Good Testing Still Has Limits

Testing remains an important tool for development teams.

At the same time, testing only answers the question that was asked. We have seen situations where a material performed exactly as expected under one set of conditions but behaved differently under another. We have also seen accelerated aging programs produce results that required additional investigation because the aging mechanism turned out to be more complicated than conventional assumptions suggested.

The issue is not necessarily that the testing was wrong. The issue is that understanding material behavior often requires a deeper understanding of the material chemistry and how the material will actually be used, challenged, and aged over time.

Looking Beyond the Design Requirements

As medical devices become more sophisticated, the number of factors influencing success continues to grow. Mechanical performance requirements remain essential, but they are only part of the picture. Manufacturing realities, sterilization strategies, regulatory expectations, and supply-chain considerations can all influence whether a product ultimately reaches patients successfully.

Development decisions rarely exist in isolation. A material selected for performance may also be affected by manufacturing, sterilization, regulatory strategy, and long-term availability.

The challenge is understanding how these factors interact throughout a product’s life and recognizing when a decision made to solve one problem may create another elsewhere in the development process.

Successful programs account for those interactions early. Ultimately, material selection must account for many aspects of development, from manufacturing and sterilization to regulatory review and commercial success.

That broader perspective often separates a material that works in development from a material that succeeds in the marketplace.

Learn more at campoly.com and visit Booth 1036 to speak with Gavin Braithwaite, CEO; Becky Bader, Director of Regulatory Services; and Veronica Holmes, Technical Sales Manager.